GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Codupha Central Pharmaceutical JSC (HSTC:CDP) » Definitions » EBIT

Codupha Central Pharmaceutical JSC (HSTC:CDP) EBIT : ₫ Mil (TTM As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Codupha Central Pharmaceutical JSC EBIT?

Codupha Central Pharmaceutical JSC's earnings before interest and taxes (EBIT) for the six months ended in . 20 was ₫0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.


Codupha Central Pharmaceutical JSC EBIT Historical Data

The historical data trend for Codupha Central Pharmaceutical JSC's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codupha Central Pharmaceutical JSC EBIT Chart

Codupha Central Pharmaceutical JSC Annual Data
Trend
EBIT

Codupha Central Pharmaceutical JSC Semi-Annual Data
EBIT

Competitive Comparison of Codupha Central Pharmaceutical JSC's EBIT

For the Pharmaceutical Retailers subindustry, Codupha Central Pharmaceutical JSC's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Codupha Central Pharmaceutical JSC's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Codupha Central Pharmaceutical JSC's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Codupha Central Pharmaceutical JSC's EV-to-EBIT falls into.


;
;

Codupha Central Pharmaceutical JSC EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in . 20 was ₫ Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Codupha Central Pharmaceutical JSC  (HSTC:CDP) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Codupha Central Pharmaceutical JSC's annualized ROC % for the quarter that ended in . 20 is calculated as:

ROC % (Q: . 20 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: . 20 ) + Invested Capital (Q: . 20 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

Codupha Central Pharmaceutical JSC's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

ROC (Joel Greenblatt) %(Q: . 20 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: . 20  Q: . 20
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=/( ( ( + max(, 0)) + ( + max(, 0)) )/ )
=/( ( + )/ )
=/
= %

where Working Capital is:

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Codupha Central Pharmaceutical JSC's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: . 20 )
=/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Codupha Central Pharmaceutical JSC EBIT Related Terms

Thank you for viewing the detailed overview of Codupha Central Pharmaceutical JSC's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Codupha Central Pharmaceutical JSC Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
334 To Hien Thanh, ward 14 District 10, Ho Chi Minh, VNM
Codupha Central Pharmaceutical JSC is a Vietnam-based pharmaceutical distribution company. It offers its services to the entire healthcare system: hospitals, medical centers, pharmaceutical companies, pharmacies from central to local levels.